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 Relative to adults without obesity, adults with obesity (BMI ≥ 30 
kg/m2) incur 42% higher medical costs1 and are nearly twice as 
likely to die before age 70.2 Nonetheless, coverage for these 
obesity treatment modalities is inconsistent across states. 
 Nutritional/behavioral counseling, pharmacotherapy, and 
bariatric surgery are evidence-based strategies that support 
clinically-significant weight loss ( ≥ 5% reduction in body 
weight).3,4
 Examine changes in coverage for adult obesity prevention 
and treatment services in Medicaid and state employee 
health programs between the 2009/2010 and 2016/2017 
plan years.
 Data were obtained through an extensive review of 
administrative documents, health plan websites, provider 
manuals, subscriber handbooks, fee schedules, and drug 
formularies from Medicaid and state employee health 
insurance programs in all fifty states and D.C.
 Some states have bolstered coverage for evidence-based 
obesity treatment modalities since 2009, but many states 
continued to deny reimbursement for non-surgical obesity 
treatment options that are supported by clinical consensus and 
evidence-based recommendations.
 Coverage was frequently restricted by stringent prior 
authorization criteria and other cost-management strategies.
 Unclear guidance on what constitutes appropriate and 
reimbursable care for obesity-related services likely prevents 
providers from referring highly-motivated beneficiaries with 
obesity to effective care.
 Where reimbursement for evidence-based obesity treatments 
has expanded, educating providers and beneficiaries about the 
availability and proper utilization of these services may 
improve obesity-related health outcomes. 
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Covered Strong evidence of possible coverage for non-pregnant 
adults (21+ years) in at least one plan
Non-Covered Strong evidence that coverage is excluded for non-
pregnant adults (21+ years)
Undetermined Absent or contradictory evidence of coverage for non-
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Figure 1. Evidence of coverage for adult obesity treatment modalities increased between 2009 and 2017. Numbers represent states 
where possibility of coverage was indicated with or without restrictions (see Discussion). 
Evidence of coverage for adult obesity treatment services, 2017
Common coverage limitations for obesity treatment modalities (2017)*
Nutrition Counseling Drug Therapy Bariatric Surgery
Medicaid Employee Medicaid Employee Medicaid Employee
Not all plans covered 10% 2% 19% 39% 2% 14%
Comorbidity required 5% 7% 25% 4% 45% 2%
Annual / lifetime cap 45% 64% - - - -
* Percentages based on states that indicated possible coverage for modality in PY16/17
Figure 2. Expected coverage for obesity treatment modalities. Cross-hatching indicates states where evidence changed from 
“non-covered / undetermined” (PY09/10) to “covered” (PY16/17).
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